VIR

Vir Biotechnology INC

+$547.8M

Net Activity

Institutions Holding

254

Popularity Rank

#2335

Avg Weight

0.25%

Total Value

$1.2B

Ownership Trend

254 institutions currently hold VIR, with 179 net buyers and 73 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Majority Increased

Based on recent trading activity

Net Selling Institutions

73

Net Buying Institutions

179

Key Holders

View all 254 holding institutions

Quarterly Activity

Recent Activity

+$751.3M

Total Buy Value

$190.6M

Total Sell Value

New buy59
Trim44
Add120
Sold out29

179

Net Buyers

73

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

1

Filings (90d)

$165K

Total Est. Value

16K shares

Planned Shares

Last Filed 2026-06-29
FilerFiling DateEst. Value
Ramasastry Saira2026-06-29$165K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding VIR BIOTECHNOLOGY INC (VIR)?
Major stakeholders currently include BlackRock, Inc. ($161.3M), ARCH Venture Management, LLC ($115.7M), Sb Investment Advisers (uk) LTD ($98.1M). Based on the latest 13F filings, there are a total of 254 tracked investment funds and institutions maintaining positions in VIR.
What is the overall institutional sentiment toward VIR recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $547.8M, driven by 179 managers accumulating shares while 73 reduced their exposure.
Which institutions have been selling or reducing their VIR positions?
In the latest period, 44 funds trimmed their holdings, and 29 managers completely exited their positions. The aggregate reported sell value was $190.6M.
Are there any notable investors adding VIR to their portfolios?
Yes, buying activity remains notable. 59 institutions opened new positions in {ticker}, and 120 existing holders added to their shares. The total reported buy value for the quarter amounted to $751.3M.

Related Stocks